<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
   <channel>
      <title>The Earth Times Press Release - drugs</title>
      <link>http://www.earthtimes.org</link>
      <description>The Earth Times online newspaper, serving the planet with news that matters. Covering current affairs, world news, environmental affairs and sport</description>
      <language>en-us</language>
      <generator>PHP/4.4.4</generator>
      <item>
         <title>1-800-GOT-MOLD?&amp;rsquo;s Dog Detectives Have a Leg Up on the Competition</title>
         <link>http://www.earthtimes.org/articles/show/1-800-got-moldrsquos-dog-detectives-have-a-leg-up-on-the-competition,1050784.shtml</link>
         <description>PRINCETON, N.J. - 
      Used throughout human history to locate everything from bombs and drugs 
      to missing persons, canines are now being utilized to detect potentially 
      lethal </description>
		 <category>PressRelease</category>
         <pubDate>Tue, 17 Nov 2009 20:53:30 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/1-800-got-moldrsquos-dog-detectives-have-a-leg-up-on-the-competition,1050784.shtml</guid>
      </item>
      <item>
         <title>Cambridge-based Ligon Discovery Raises $1M in Seed Funding</title>
         <link>http://www.earthtimes.org/articles/show/cambridge-based-ligon-discovery-raises-1m-in-seed-funding,1055666.shtml</link>
         <description>

CAMBRIDGE, Mass., Nov. 19 /PRNewswire/ -- Ligon Discovery, Inc., which uses proprietary small molecule microarray technology to find drugs against high-value targets, today announced that it has raised $1M in seed financing led by incTANK Ventures. The company will use the capital to co...</description>
		 <category>PressRelease</category>
         <pubDate>Thu, 19 Nov 2009 19:02:24 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/cambridge-based-ligon-discovery-raises-1m-in-seed-funding,1055666.shtml</guid>
      </item>
      <item>
         <title>AVI BioPharma, Inc. Presents Update on AVI-4658 at TREAT-NMD / NIH International Conference</title>
         <link>http://www.earthtimes.org/articles/show/avi-biopharma-inc-presents-update,1054431.shtml</link>
         <description>BOTHELL, WA -- 11/19/09 -- 
 AVI BioPharma, Inc. (NASDAQ: AVII), a developer
of RNA-based drugs, today announced presentations on the company's exon
skipping therapy for Duchenne muscular dystrophy at the TREAT-NMD / NIH
International Conference taki..</description>
		 <category>PressRelease</category>
         <pubDate>Thu, 19 Nov 2009 13:02:04 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/avi-biopharma-inc-presents-update,1054431.shtml</guid>
      </item>
      <item>
         <title>OSI Pharmaceuticals Announces Tarceva to Be Reviewed by the FDA's Oncologic Drugs Advisory Committee for Use as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer</title>
         <link>http://www.earthtimes.org/articles/show/osi-pharmaceuticals-announces-tarceva-to,1047175.shtml</link>
         <description>MELVILLE, N.Y. - 
      OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that the 
      Oncologic Drugs Advisory Committee (ODAC) will review the use of Tarceva&amp;reg; 
      (erlotinib) as a first-line maintenance therapy for patients with 
      advanced non-small cell lung cancer (NSCLC) who have n</description>
		 <category>PressRelease</category>
         <pubDate>Mon, 16 Nov 2009 15:54:49 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/osi-pharmaceuticals-announces-tarceva-to,1047175.shtml</guid>
      </item>
      <item>
         <title>Potent Anti-tumor PARP Inhibitor Discovered by LEAD Therapeutics</title>
         <link>http://www.earthtimes.org/articles/show/potent-anti-tumor-parp-inhibitor-discovered-by-lead-therapeutics,1046421.shtml</link>
         <description>SAN BRUNO, Calif. &amp;amp; SHANGHAI - 
      LEAD Therapeutics, a privately held drug discovery company, today 
      announced the discovery of a novel, orally available, PARP inhibitor 
      with potent anti-tumor activity both as single-agent treatment and in 
      combination with chemotherapy drugs. The new compoun</description>
		 <category>PressRelease</category>
         <pubDate>Mon, 16 Nov 2009 13:21:41 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/potent-anti-tumor-parp-inhibitor-discovered-by-lead-therapeutics,1046421.shtml</guid>
      </item>
      <item>
         <title>Lotus Pharmaceuticals, Inc. Reports Third-Quarter 2009 Results</title>
         <link>http://www.earthtimes.org/articles/show/lotus-pharmaceuticals-inc-reports-third-quarter-2009-results,1046283.shtml</link>
         <description>

    BEIJING, Nov. 16 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc.
(OTC Bulletin Board: LTUS) (&amp;quot;Lotus&amp;quot; or the &amp;quot;Company&amp;quot;) a growing developer and
producer of prescriptions drugs and licensed national seller of pharmaceutical
pr...</description>
		 <category>PressRelease</category>
         <pubDate>Mon, 16 Nov 2009 13:04:36 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/lotus-pharmaceuticals-inc-reports-third-quarter-2009-results,1046283.shtml</guid>
      </item>
      <item>
         <title>Sinobiopharma has Production Rights to 23 Drugs Listed in China's National Essential Drugs List</title>
         <link>http://www.earthtimes.org/articles/show/sinobiopharma-has-production-rights-to,1046044.shtml</link>
         <description>

    NANTONG, China, Nov. 16 /PRNewswire-Asia-FirstCall/ -- Sinobiopharma, Inc.
(&amp;quot;Sinobiopharma&amp;quot; or, the &amp;quot;Company&amp;quot;) (OTC Bulletin Board: SNBP) is pleased to
announce that 23 generic drugs for which the Company has production rights are
list...</description>
		 <category>PressRelease</category>
         <pubDate>Mon, 16 Nov 2009 12:00:34 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/sinobiopharma-has-production-rights-to,1046044.shtml</guid>
      </item>
      <item>
         <title>Breaking the News, or Fueling the Epidemic? News Coverage of Opioid-Related Deaths Often Precede an Increase in Deaths, Study Finds</title>
         <link>http://www.earthtimes.org/articles/show/breaking-the-news-or-fueling,1052453.shtml</link>
         <description>

BOSTON, Nov. 18 /PRNewswire-USNewswire/ -- Increases in deaths from opioid drugs such as OxyContin may be linked to the volume of coverage such deaths receive in the news, according to a study from Children's Hospital Boston and the University of North Carolina (UNC), Chapel Hill. The s...</description>
		 <category>PressRelease</category>
         <pubDate>Wed, 18 Nov 2009 14:52:50 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/breaking-the-news-or-fueling,1052453.shtml</guid>
      </item>
      <item>
         <title>instaCare Corp. Continues Turnaround, Reports 58% Revenues Increase for First Three Quarters</title>
         <link>http://www.earthtimes.org/articles/show/instacare-corp-continues-turnaround-reports,1052318.shtml</link>
         <description>

LOS ANGELES, Nov. 18  -- instaCare Corp., (OTC Bulletin Board: ISCR), a leading distributor of life-saving prescription drugs and at-home testing diagnostics for the chronically ill, and a leading developer of patentable technologies for e-pharmacy, e-he...</description>
		 <category>PressRelease</category>
         <pubDate>Wed, 18 Nov 2009 14:15:55 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/instacare-corp-continues-turnaround-reports,1052318.shtml</guid>
      </item>
      <item>
         <title>Pfizer and DNDi Advancing International Research Efforts In The Fight Against Neglected Tropical Diseases</title>
         <link>http://www.earthtimes.org/articles/show/pfizer-and-dndi-advancing-international,1052109.shtml</link>
         <description>NEW YORK &amp;amp; GENEVA - 
      Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) 
      have signed an agreement that is designed to facilitate advancements in 
      the battle against human African trypanosomiasis (HAT), visceral 
      leishmaniasis (VL) and Chagas disease, which afflict vu</description>
		 <category>PressRelease</category>
         <pubDate>Wed, 18 Nov 2009 13:47:40 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/pfizer-and-dndi-advancing-international,1052109.shtml</guid>
      </item>
      <item>
         <title>PharmaShack.com Embraces Fall - Offers 15 Percent Off of All Meds on Site</title>
         <link>http://www.earthtimes.org/articles/show/pharmashackcom-embraces-fall--offers,1045777.shtml</link>
         <description>
PharmaShack.com - an online pharmacy selling over the counter drugs offers a special fall discount of 15% off on all items, and a new and exciting range of new dietary products such as Hoodia, Mega Hoodia and Acai herbs./I/P
P(PRWEB) November 16, 2009 -- It seems that everyone needs med...</description>
		 <category>PressRelease</category>
         <pubDate>Mon, 16 Nov 2009 08:23:40 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/pharmashackcom-embraces-fall--offers,1045777.shtml</guid>
      </item>
      <item>
         <title>American Heart Association Late Breaking Clinical Trial Report: Tests Predict Which Patients Are Resistant to Anti-Clotting Therapy During Angioplasty, Stenting</title>
         <link>http://www.earthtimes.org/articles/show/american-heart-association-late-breaking,1045553.shtml</link>
         <description>

Study highlights: 
-- Three of six platelet reactivity tests predicted a risk of adverse outcomes related to blood clots in patients receiving two anti-clotting drugs following angioplasty (PCI) plus stenting.
-- Three other tests failed to predict excess risk....</description>
		 <category>PressRelease</category>
         <pubDate>Sun, 15 Nov 2009 13:00:56 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/american-heart-association-late-breaking,1045553.shtml</guid>
      </item>
      <item>
         <title>DopeStats.com Provides Statistical Information on Legal and Illegal Drugs in Each U.S. County</title>
         <link>http://www.earthtimes.org/articles/show/dopestatscom-provides-statistical-information-on,1058056.shtml</link>
         <description>
Information about drug use and drug information is now just a click away with the recently launched DopeStats.com. The new site is an online statistical database documenting drug use in more than 3,000 counties in the United States. The data is compiled by anonymous users on drugs and herbs f...</description>
		 <category>PressRelease</category>
         <pubDate>Sun, 22 Nov 2009 18:54:08 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/dopestatscom-provides-statistical-information-on,1058056.shtml</guid>
      </item>
      <item>
         <title>Synta Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090</title>
         <link>http://www.earthtimes.org/articles/show/synta-presents-preclinical-data-on-next-generation-hsp90-inhibitor-sta-9090,1051984.shtml</link>
         <description>LEXINGTON, Mass. - 
      Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company 
      focused on discovering, developing, and commercializing small molecule 
      drugs to treat severe medical conditions, today announced that 
      preclinical data presented at the AACR-NCI-EORTC Conference on Mole</description>
		 <category>PressRelease</category>
         <pubDate>Wed, 18 Nov 2009 13:29:24 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/synta-presents-preclinical-data-on-next-generation-hsp90-inhibitor-sta-9090,1051984.shtml</guid>
      </item>
      <item>
         <title>Synta Presents New Data on Mechanism of Action of Elesclomol at AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics</title>
         <link>http://www.earthtimes.org/articles/show/synta-presents-new-data-on,1051868.shtml</link>
         <description>LEXINGTON, Mass. - 
      Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company 
      focused on discovering, developing, and commercializing small molecule 
      drugs to treat severe medical conditions, today presented new data on 
      the mechanism of action of elesclomol, a first-in-class oxid</description>
		 <category>PressRelease</category>
         <pubDate>Wed, 18 Nov 2009 13:16:21 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/synta-presents-new-data-on,1051868.shtml</guid>
      </item>
      <item>
         <title>Generic Drugs Just as Effective as Brand Name Drugs Says DoctorSolve</title>
         <link>http://www.earthtimes.org/articles/show/generic-drugs-just-as-effective-as-brand-name-drugs-says-doctorsolve,1053907.shtml</link>
         <description>
Despite years of controversy, new study finds that generic drugs to be equally as effective as brand name drugs./I/P
P(PRWEB) November 19, 2009 -- A recent publication in the October issue of The Medical Letter may help to eliminate the fear many people have about generic drugs. A syste...</description>
		 <category>PressRelease</category>
         <pubDate>Thu, 19 Nov 2009 08:16:51 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/generic-drugs-just-as-effective-as-brand-name-drugs-says-doctorsolve,1053907.shtml</guid>
      </item>
      <item>
         <title>Latest Trend to Lose Weight: Nutritional Body Cleansing</title>
         <link>http://www.earthtimes.org/articles/show/latest-trend-to-lose-weight-nutritional-body-cleansing,1056411.shtml</link>
         <description>
Most of us are exposed to doctors, hospitals and taught to take prescription medication (drugs) to treat the symptoms of the life illnesses and weight loss.  Through the use of natural a href= http://www.cleansingandnutrition.com/  onclick= linkClick( this.href );   target= _blank  title= bo...</description>
		 <category>PressRelease</category>
         <pubDate>Fri, 20 Nov 2009 08:27:54 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/latest-trend-to-lose-weight-nutritional-body-cleansing,1056411.shtml</guid>
      </item>
      <item>
         <title>Michael Jackson Propofol Expert, Dr. Barry Friedberg, to Speak in Veracruz</title>
         <link>http://www.earthtimes.org/articles/show/michael-jackson-propofol-expert-dr-barry-friedberg-to-speak-in-veracruz,1048472.shtml</link>
         <description>
Brain monitoring of Jackson's propofol could have saved his life despite the other drugs in his body. For the second consecutive year, propofol expert, Dr. Barry Friedberg will address the annual Congress of Mexican Anesthesiologists, this year in Veracruz, Mexico. Also, an expert on brain mo...</description>
		 <category>PressRelease</category>
         <pubDate>Tue, 17 Nov 2009 08:13:47 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/michael-jackson-propofol-expert-dr-barry-friedberg-to-speak-in-veracruz,1048472.shtml</guid>
      </item>
      <item>
         <title>Buy Generic Levitra Online and Avoid Uncomfortable Situations</title>
         <link>http://www.earthtimes.org/articles/show/buy-generic-levitra-online-and-avoid-uncomfortable-situations,1048383.shtml</link>
         <description>Convenience, privacy and sometimes drugs at a more affordable price are some major advantages an online pharmacy provides. It’s only a click of a button - the internet provides the convenience of ordering from their bedrooms in complete privacy, helping people who find it embarrassing to order for medicines.</description>
		 <category>PressRelease</category>
         <pubDate>Tue, 17 Nov 2009 07:04:40 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/buy-generic-levitra-online-and-avoid-uncomfortable-situations,1048383.shtml</guid>
      </item>
      <item>
         <title>Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology</title>
         <link>http://www.earthtimes.org/articles/show/champions-biotechnology-enters-into-licensing,1051738.shtml</link>
         <description>

BALTIMORE, Nov. 18  -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclu...</description>
		 <category>PressRelease</category>
         <pubDate>Wed, 18 Nov 2009 13:03:48 GMT</pubDate>
         <guid isPermaLink="true">http://www.earthtimes.org/articles/show/champions-biotechnology-enters-into-licensing,1051738.shtml</guid>
      </item>
   </channel>
</rss>